CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic  leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo

Mladonická Pavlasová,  Gabriela; Borský,  Marek; Svobodová, Veronika; Oppelt,  Jan; Amruz Černá,  Kateřina; Novotná,  Jitka; Musilová,  Kateřina; Šeda,  Václav; Hoferková,  Eva; Brychtová,  Yvona; Doubek,  Michael; Pospíšilová,  Šárka; Mayer,  Jiří; Mráz,  Marek

CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	PAVLASOVÁ Gabriela BORSKÝ Marek SVOBODOVÁ Veronika OPPELT Jan AMRUZ ČERNÁ Kateřina NOVOTNÁ Jitka MUSILOVÁ Kateřina ŠEDA Václav VOJÁČKOVÁ Eva BRYCHTOVÁ Yvona DOUBEK Michael POSPÍŠILOVÁ Šárka MAYER Jiří MRÁZ Marek
Year of publication	2018
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation
Description	CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo, CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo.
Related projects:	MEDGENET - Medical genomics and epigenomics network CEITEC 2020 Vliv terapeutické inhibice BCR signalizace na genovou expresi u B buněčných malignit a její prognostický a prediktivní význam Coding and Non-coding RNA Networks that Regulate B Cell Receptor Signalling: Implications for Combinatorial Therapy Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V